OMER Omeros Corp

Price (delayed)

$17.35

Market cap

$1.26B

P/E Ratio

9.08

Dividend/share

N/A

EPS

$1.91

Enterprise value

$1.55B

?
Relative Growth: Rel. Growth: 31
Relative Strength: Rel. Strength: 97
Relative Valuation: Rel. Valuation: 85
Relative Profitability: Rel. Profitability: 56

Omeros is an innovative biopharmaceutical company committed to discovering, developing and commercializing first-in-class small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases and cancers, ...

Highlights
The EPS has surged by 190% year-on-year and by 47% since the previous quarter
OMER's equity has surged by 78% year-on-year and by 19% since the previous quarter
Omeros's quick ratio has decreased by 35% from the previous quarter

Key stats

What are the main financial stats of OMER

OMER stock price

How has the Omeros stock price performed over time
Intraday
26.55%
1 week
31.94%
1 month
73.33%
1 year
306.32%
YTD
1.02%
QTD
82.44%

Financial performance

How have Omeros's revenue and profit performed over time
Revenue
$38.42M
Gross profit
$37.04M
Operating income
-$72.82M
Net income
$124.83M
Gross margin
96.4%
Net margin
324.9%
The operating margin has soared by 82% from the previous quarter
The net margin has dropped by 63% since the previous quarter
Omeros's operating income has increased by 46% YoY and by 31% from the previous quarter
The net income has grown by 45% from the previous quarter

Price vs fundamentals

How does OMER's price correlate with its fundamentals

Growth

What is Omeros's growth rate over time

Valuation

What is Omeros stock price valuation
P/E
9.08
P/B
N/A
P/S
32.57
EV/EBIT
11.42
EV/EBITDA
11.35
EV/Sales
40.36
The EPS has surged by 190% year-on-year and by 47% since the previous quarter
OMER's equity has surged by 78% year-on-year and by 19% since the previous quarter

Efficiency

How efficient is Omeros business performance
The ROA has soared by 196% YoY and by 33% from the previous quarter
The return on sales has dropped by 61% since the previous quarter
Omeros's ROIC has soared by 53% from the previous quarter

Dividends

What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMER.

Financial health

How did Omeros financials performed over time
The total assets is 15% less than the total liabilities
The current ratio has soared by 141% YoY but it has contracted by 36% from the previous quarter
The total assets has grown by 43% YoY
OMER's equity has surged by 78% year-on-year and by 19% since the previous quarter
The debt has declined by 22% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.